Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.5.0.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2016
Dec. 31, 2015
Assets    
Financing receivables $ 865,481 $ 783,967
Financing receivables held-for-sale 7,378 60,376
Investments available-for-sale 50,291 29,017
Real estate 134,815 128,769
Real estate related intangible assets 30,924 26,930
Equity method investments in affiliates 323,968 318,769
Cash and cash equivalents 72,968 42,645
Other assets 70,340 79,148
Total Assets 1,556,165 1,469,621
Liabilities:    
Accounts payable, accrued expenses and other 28,015 17,875
Deferred funding obligations 64,331 108,499
Credit facilities 356,419 247,350
Nonrecourse debt (secured by assets of $763 million and $815 million, respectively) 610,267 663,791
Total Liabilities 1,059,032 1,037,515
Stockholders' Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 41,989,485 and 37,010,603 shares issued and outstanding, respectively 420 370
Additional paid in capital 578,107 482,431
Retained deficit (80,865) (52,701)
Accumulated other comprehensive loss (4,289) (1,905)
Non-controlling interest 3,760 3,911
Total Stockholders' Equity 497,133 432,106
Total Liabilities and Stockholders' Equity $ 1,556,165 $ 1,469,621